Delivery Order SPE2DB20D3103-SPE2DB25FP5U2

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,093,165 units of Enbrel 50 mg/ml syringe, a medication used to treat autoimmune disorders. The contract has a ceiling value of $4,787.86 and a period of performance through May 1, 2025. The contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp holds a substantial...

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ENBREL 50 MG/ML syringes, a medication used to treat certain autoimmune disorders. The contract has a firm fixed price, a ceiling value of $65,732.01, and a period of performance through April 17, 2025. This contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp also holds a...

The Defense Logistics Agency awarded a $35,136.89 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ENBREL 50 MG/ML SURECLICKML. The prime contractor will deliver the biologic drug from its Conshohocken, Pennsylvania facility to support DLA requirements. No major subcontractors or set aside designations were identified. ENBREL is an injectable medication used to treat moderate to severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and plaque...

This is a $25,238.66 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ENBREL 50 MG/ML SYRINGEML, a medication used to treat various autoimmune conditions. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENBREL 50 MG/ML SYRINGEML, a pharmaceutical product, with a ceiling value of $14,527.48 and a performance period ending on June 18, 2025. The award is not set aside and represents open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...

The Defense Logistics Agency awarded a $39,159.70 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ENBREL 50 MG/ML SURECLICK autoinjector pens. To be performed in Conshohocken, Pennsylvania from August 24-25, 2023, the order was placed against an existing DLA contract vehicle to supply the pharmaceutical product ENBREL for the treatment of autoimmune diseases such as rheumatoid arthritis from the prime contractor's parent company Amerisourcebergen Corporation. No set...

This is a $42,189.82 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Enbrel 50 mg/mL SureClick 1 mL injections to support federal healthcare programs, particularly military and veterans' healthcare systems. The contract is not designated as a set-aside. It is a part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery...

This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of ENBREL 50 MG/ML SYRINGEML, a specialty pharmaceutical product, with a potential value of $31,413.54 and a period of performance through January 29, 2024. This order is issued under an indefinite delivery contract (IDC) held by Amerisourcebergen...

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Enbrel 25 mg/0.5 ml syringes, a medication used to treat autoimmune diseases. The contract has a ceiling value of $31,487.74 and a period of performance through May 1, 2025. It is a firm-fixed-price contract, with no set-aside designation, indicating open competition....

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ENBREL 50 MG/ML SURECLICK syringes, a medication used to treat various autoimmune conditions. The contract has a ceiling value of $65,758.34 and a period of performance ending on June 9, 2025. It is not designated as a set-aside contract, indicating open competition....